GlaxoSmithKline PLC ADR (GSK) — Free Cash Flow Generation Index
GlaxoSmithKline PLC ADR (GSK) has a Free Cash Flow Generation Index of 0.87x as of June 2026. Free cash flow of $2.21 Billion represents 1% of operating cash flow ($2.54 Billion). Explore capital reinvestment ratio of GlaxoSmithKline PLC ADR to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GlaxoSmithKline PLC ADR Free Cash Flow Generation Index (1990–2025)
Historical FCF Generation Index trend for GlaxoSmithKline PLC ADR across 36 annual periods. For the full cash flow conversion analysis, see GlaxoSmithKline PLC ADR (GSK) cash flow conversion.
Annual Free Cash Flow Generation for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year Free Cash Flow Generation Index for GlaxoSmithKline PLC ADR. Check GlaxoSmithKline PLC ADR total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | $5.82 Billion | $7.14 Billion | $1.32 Billion | ▲ +49.6% |
| 2024 | 0.55x | $3.57 Billion | $6.55 Billion | $2.98 Billion | ▼ -31.3% |
| 2023 | 0.79x | $6.26 Billion | $7.89 Billion | $1.63 Billion | ▲ +14.1% |
| 2022 | 0.69x | $5.14 Billion | $7.40 Billion | $2.26 Billion | ▲ +10.1% |
| 2021 | 0.63x | $5.02 Billion | $7.95 Billion | $2.93 Billion | ▼ -14.1% |
| 2020 | 0.73x | $6.20 Billion | $8.44 Billion | $2.24 Billion | ▲ +0.6% |
| 2019 | 0.73x | $5.86 Billion | $8.02 Billion | $2.16 Billion | ▼ -7.2% |
| 2018 | 0.79x | $6.62 Billion | $8.42 Billion | $1.80 Billion | ▲ +15.4% |
| 2017 | 0.68x | $4.72 Billion | $6.92 Billion | $2.20 Billion | ▲ +6.9% |
| 2016 | 0.64x | $4.14 Billion | $6.50 Billion | $2.35 Billion | ▲ +145.4% |
| 2015 | 0.26x | $668.00 Million | $2.57 Billion | $1.90 Billion | ▼ -60.7% |
| 2014 | 0.66x | $3.42 Billion | $5.18 Billion | $1.75 Billion | ▼ -13.4% |
| 2013 | 0.76x | $5.52 Billion | $7.22 Billion | $1.70 Billion | ▲ +17.1% |
| 2012 | 0.65x | $2.85 Billion | $4.38 Billion | $1.52 Billion | ▼ -17.1% |
| 2011 | 0.79x | $4.92 Billion | $6.25 Billion | $1.33 Billion | ▲ +3.7% |
| 2010 | 0.76x | $5.16 Billion | $6.80 Billion | $1.64 Billion | ▼ -0.2% |
| 2009 | 0.76x | $5.97 Billion | $7.84 Billion | $1.87 Billion | ▲ +6.2% |
| 2008 | 0.72x | $5.24 Billion | $7.31 Billion | $2.07 Billion | ▲ +21.1% |
| 2007 | 0.59x | $3.65 Billion | $6.17 Billion | $2.14 Billion | ▲ +2.0% |
| 2006 | 0.58x | $2.37 Billion | $4.08 Billion | $1.59 Billion | ▼ -18.3% |
| 2005 | 0.71x | $4.41 Billion | $6.20 Billion | $1.18 Billion | ▼ -22.1% |
| 2004 | 0.91x | $4.51 Billion | $4.94 Billion | $255.00 Million | ▲ +16.9% |
| 2003 | 0.78x | $3.79 Billion | $4.85 Billion | $1.06 Billion | ▲ +30.4% |
| 2002 | 0.60x | $1.83 Billion | $3.06 Billion | $1.23 Billion | ▼ -20.9% |
| 2001 | 0.76x | $3.49 Billion | $4.61 Billion | $1.12 Billion | ▲ +87.3% |
| 2000 | 0.40x | $749.00 Million | $1.85 Billion | $1.10 Billion | ▲ +337.1% |
| 1999 | -0.17x | $-87.00 Million | $510.00 Million | $597.00 Million | ▼ -7.6% |
| 1998 | -0.16x | $-65.00 Million | $410.00 Million | $475.00 Million | ▼ -148.8% |
| 1997 | 0.33x | $200.00 Million | $615.00 Million | $415.00 Million | ▼ -38.4% |
| 1996 | 0.53x | $448.00 Million | $849.00 Million | $401.00 Million | ▲ +16.3% |
| 1995 | 0.45x | $568.00 Million | $1.25 Billion | $684.00 Million | ▼ -43.4% |
| 1994 | 0.80x | $1.96 Billion | $2.45 Billion | $485.59 Million | ▲ +76.6% |
| 1993 | 0.45x | $478.00 Million | $1.05 Billion | $575.00 Million | ▲ +31.9% |
| 1992 | 0.34x | $319.00 Million | $927.00 Million | $608.00 Million | ▲ +258.9% |
| 1991 | 0.10x | $63.00 Million | $657.00 Million | $594.00 Million | ▲ +555.3% |
| 1990 | 0.01x | $9.00 Million | $615.00 Million | $606.00 Million | — |